SUN PHARMACEUTICAL IND L vs Rekvina Labs Ltd
A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and Rekvina Labs Ltd (VINRKLB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs VINRKLB on 7 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability22
- Growth· not comparable—
- Size & financial health31
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
- + ["Promoter holding has increased by 35.7% over last quarter."]
- − ["Company has low interest coverage ratio."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.